Optimization of the encapsulation efficiency of a novel oral insulin delivery nanosystem
Oral delivery of insulin may significantly improve the quality of life of diabetes patients who routinely receive insulin by the subcutaneous route. The oral delivery of insulin remains a challenge because of its limited absorption. The main goal of this study was to produce stable nanoparticles wit...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
ALIES - Associação Lusófona para o Desenvolvimento da Investigação e do Ensino das Ciências da Saúde
2014-06-01
|
Series: | Journal Biomedical and Biopharmaceutical Research (BBR) |
Subjects: | |
Online Access: | http://www.alies.pt/BBR%20Editions/Vol-11-1-2014/art%204_bf.pdf |
Summary: | Oral delivery of insulin may significantly improve the quality of life of diabetes patients who routinely receive insulin by the subcutaneous route. The oral delivery of insulin remains a challenge because of its limited absorption. The main goal of this study was to produce stable nanoparticles with high loads of insulin for further in vivo testing. Poli(lactic-co-glycolic acid) (PLGA), a biodegradable and biocompatible polymer, revealed to be a good presupposition for this approach. Nanoparticles were produced through a multiple emulsion method and the encapsulation efficiency was accessed by a HPLC method.
Monodispersed nanoparticles were produced and the insulin EE were improved from 30 % to 65 %, controlling parameters such as the stirring speed rate, volume of external phase, pH range, type of insulin, type of surfactant and polymer concentrations. The nanoparticle size was 398.6 nm with a polydispersivity index of 0.19. The presence of a salt concentration between 20 g L-1 and 50 g L-1 and the type of insulin decreased the size of nanoparticles. Bioactivity assessment after the encapsulation
process and full characterization of physical-chemical interactions between all species is now required. |
---|---|
ISSN: | 2182-2360 2182-2379 |